{
    "organizations": [],
    "uuid": "93e2858c3145ffdfc2469c0b4f272a91ab3edaae",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-array-biopharma-says-entered-into/brief-array-biopharma-says-entered-into-controlled-equity-offerings-sales-agreement-with-cantor-fitzgerald-idUSFWN1SG18Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Array Biopharma Says Entered Into Controlled Equity Offerings Sales Agreement With Cantor Fitzgerald",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Array Biopharma Inc:\n* ARRAY BIOPHARMA INC SAYS ENTERED INTO CONTROLLED EQUITY OFFERINGSM SALES AGREEMENT WITH CANTOR FITZGERALD & CO - SEC FILING\n* ARRAY BIOPHARMA INC SAYS MAY OFFER AND SELL UP TO $125.0 MILLION OF COMMON STOCK OF THROUGH CANTOR FITZGERALD & CO Source text: ( bit.ly/2FY8NeE ) Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-09T20:38:00.000+03:00",
    "crawled": "2018-05-10T17:39:56.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "array",
        "biopharma",
        "inc",
        "array",
        "biopharma",
        "inc",
        "say",
        "entered",
        "controlled",
        "equity",
        "offeringsm",
        "sale",
        "agreement",
        "cantor",
        "fitzgerald",
        "co",
        "sec",
        "filing",
        "array",
        "biopharma",
        "inc",
        "say",
        "may",
        "offer",
        "sell",
        "million",
        "common",
        "stock",
        "cantor",
        "fitzgerald",
        "co",
        "source",
        "text",
        "company",
        "coverage"
    ]
}